Teal, Aluna, Levels
Data analytics startup Clearsense scores $50M and more digital health fundings
Healthcare data analytics startup Clearsense raised $50 million in a Series D funding round led by HealthQuest Capital, with participation from Health Catalyst Capital and UPMC Enterprises.
Along with the funding, Anthony Williams, partner at HealthQuest, will join Clearsense's board. The startup raised $30 million in funding in 2021.
Led by Gene Scheurer, Clearsense's mission to unlock the full potential of healthcare data by delivering solutions that empower data confidence and enable data-driven decision-making to achieve better outcomes has been further strengthened by this investment.
Data analytics startup Clearsense scores $50M and more digital health fundings | MobiHealthNews
Respiratory health monitoring company Aluna raised $15.3 million, and virtual applied behavior analysis therapy provider AnswersNow scooped up $11 million.
Aluna Raises $15.3M in Series B Funding To Empower Asthma, COPD and Cystic Fibrosis Patients and Their Doctors
Aluna, the award-winning lung health management platform, today announced it has completed a $15.3 million Series B round of financing to continue growing its solution among doctors and patients managing asthma, cystic fibrosis and COPD.
Aluna’s AI-enabled respiratory management platform allows patients to transmit data to their doctor by blowing into their innovative spirometer daily. The patient-facing app gives patients an easy way to collect symptoms, medication, activity, and environmental factors. Their proprietary ML algorithms help medical teams identify respiratory problems and take corrective action to keep their health under control.
Led by previous investor Matrix Partners, the Series B round brings Aluna’s total funding since inception to $27 million. Key investors in the round also include New York-based Rho Ignition, and Dr. Warner Carr, an Irvine, California-based allergist whose practice is an early adopter of Aluna’s platform. The Series B funding comes on the heels of a year of rapid growth, with Aluna adding thousands of new patients to its platform for a year-over-year growth rate of 10x. The company plans to invest both on the product and commercial side to produce more spirometers, make its offering more robust and reach new patients.
Aluna Raises $15.3M in Series B Funding To Empower Asthma, COPD and Cystic Fibrosis Patients and Their Doctors | Business Wire
Aluna, the award-winning lung health management platform, today announced it has completed a $15.3 million Series B round of financing to continue gro
Teal unwraps $8.8M to build out a telehealth platform for women — starting with cervical cancer screening
Female-focused telehealth startup, Teal Health, is popping up today to announce an $8.8 million seed round with a roster of heavy hitting investors on board — including (Serena Williams’) Serena Ventures, (Chelsea Clinton’s) Metrodora Ventures, and (Laurene Powell Jobs’) Emerson Collective.
The February 2020-founded San Francisco-based startup’s first product will be a service that supports women to collect their own sample for cervical cancer screening in the comfort of their own home.
It wants to tackle the problem of women not getting screened — either because the traditional route of going to a doctor’s surgery for a pap smear (using a speculum) is uncomfortable or inconvenient or both.
Teal has developed a novel device for women to self collect a sample to mail off for lab analysis. Its websites refers to this device as a “collection wand” — and we gather there’s a sponge involved — but details of what exactly it looks like and how it will function remain under wraps as the startup is still in the process of applying for FDA clearance, per Teal’s CEO, Kara Egan.
Teal unwraps $8.8M to build out a telehealth platform for women – starting with cervical cancer screening | TechCrunch
Female-focused telehealth startup, Teal Health, is popping up today to announce an $8.8 million seed round with a roster of heavy hitting investors on board…
AnswersNow raises $11M in Series A funding to scale the reach of quality, personalized virtual ABA therapy
AnswersNow, the next-gen platform for digital Applied Behavior Analysis (ABA) with a mission to deliver high-quality, personalized therapy to all, today announced it has closed $11 million in Series A financing.
The round was led by Left Lane Capital, a venture capital and growth equity firm that invests in high-growth internet and consumer technology businesses. Additional backing was provided by new and existing investors, including American Family Institute for Social Impact, Blue Heron Capital, Difference Partners, and former Kadiant CEO Lani Fritts.
AnswersNow will use the funding to expand the reach of its ABA therapy services into more states across the U.S., to grow its skilled team of PhD and Master's-level clinicians, and to improve the user experience of its interactive virtual platform.
Founded in 2017, AnswersNow pairs families with a dedicated clinician for behavioral therapy sessions hosted on its custom-built virtual platform. The platform was designed with the help of clinicians to mirror the controlled environment of an in-person therapy experience. It uses special screen features that eliminate distractions and integrated activities focused on things like memory and recognition to engage clients in their care. In 2022 alone, the platform enabled the company's clinical team to facilitate 10,000+ hours of therapy.
AnswersNow raises $11M in Series A funding to scale the reach of quality, personalized virtual ABA therapy
/PRNewswire/ – AnswersNow, the next-gen platform for digital Applied Behavior Analysis (ABA) with a mission to deliver high-quality, personalized therapy to…
Levels Secures $7M Series A Extension Funding
Levels, a New York-based software company that provides real-time feedback on how food affects the health, raised $7M in Series A Extension funding.
The extension follows a $38M Series A round in April 2022, and strengthens ties with existing and new individual investors and funds like TriplePoint Capital. Existing investors include a16z, Trust Ventures, and Shrug Capital as well as notable founders and the Levels member community.
The company, which has raised more than $55M to date, intends to use the funds to expand access to its suite of member services including:
the app providing real-time feedback and guidance to help members improve their nutrition, exercise, sleep, and more;
an engaged community;
educational materials and expert insights including a podcast and blog;
access to continuous glucose monitors (CGMs) and on-demand blood testing to track metabolic markers.
Founded by Casey Means, MD (Stanford MD), Josh Clemente (SpaceX, Hyperloop), Sam Corcos (CarDash, YC), David Flinner (Google), and Andrew Conner (Google), Levels helps people see how food affects their health via a mobile application that leverages data from biosensors and other sources, such as Apple Health. By leveraging data shared by members from biosensors like continuous glucose monitors (CGM), Levels provides real-time feedback on how diet and lifestyle choices impact metabolic health. Members are using personalized data to discover their optimal diet, control their weight, and reduce long-term health risk.
Levels Secures $7M Series A Extension Funding
Levels, a New York-based software company that provides real-time feedback on how food affects the health, raised $7M in Series A Extension funding.
Frontrow Health Raises $3M in Seed Funding
Frontrow Health, an Austin, TX-based digital health startup, raised $3M in Seed funding.
The round was led by Next Coast Ventures and NextGen Venture Partners, and angel investor Andy Page.
The company intends to use the funds to scale its multi-sided marketplace as it quickly onboards more DTC brands, medical providers, and consumers.
Led by CEO and founder Irfan Alam, Frontrow tackles consumer mistrust and rising marketing costs by enabling medical providers to build digital stores, where patients can shop and save on D2C products trusted by their own providers. The platform lets providers create digital stores and earn passive income as patients click through products, while helping patients earn cash back on consumables, devices, and virtual services.
